Jorge Gómez Tejeda Zañudo

Jorge Gómez Tejeda Zañudo

Harvard University

H-index: 16

North America-United States

About Jorge Gómez Tejeda Zañudo

Jorge Gómez Tejeda Zañudo, With an exceptional h-index of 16 and a recent h-index of 16 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Systems Biology, Cancer Genomics, Network Science, Biological Physics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract GS03-09: Characterization and proposed therapeutic exploitation of fusion RNAs in metastatic breast cancers

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

484P Multi-platform characterization of HER2 expression in triple-negative breast cancer

Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender Individuals

475P Dynamics of TROP2 expression in triple-negative breast cancer

The Metastatic Breast Cancer Project: leveraging patient-partnered research to expand the clinical and genomic landscape of metastatic breast cancer and accelerate discoveries

Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab

Jorge Gómez Tejeda Zañudo Information

University

Position

Postdoctoral associate. Broad Institute, Dana-Farber Cancer Institute

Citations(all)

1557

Citations(since 2020)

1221

Cited By

803

hIndex(all)

16

hIndex(since 2020)

16

i10Index(all)

18

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Jorge Gómez Tejeda Zañudo Skills & Research Interests

Systems Biology

Cancer Genomics

Network Science

Biological Physics

Top articles of Jorge Gómez Tejeda Zañudo

Title

Journal

Author(s)

Publication Date

Abstract GS03-09: Characterization and proposed therapeutic exploitation of fusion RNAs in metastatic breast cancers

Cancer Research

Nolan Priedigkeit

Alinés Lebrón-Torres

Janny Liao

Jean-Baptiste Alberge

Stefania Morganti

...

2024/5/2

Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial

Nature Communications

Jorge Gómez Tejeda Zañudo

Romualdo Barroso-Sousa

Esha Jain

Qingchun Jin

Tianyu Li

...

2024/3/19

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

The Lancet Oncology

Sara M Tolaney

Paolo Tarantino

Noah Graham

Nabihah Tayob

Laia Parè

...

2023/3/1

484P Multi-platform characterization of HER2 expression in triple-negative breast cancer

Annals of Oncology

AC Garrido-Castro

J Gomez Tejeda Zanudo

J Navarro

ET Richardson

A Frangieh

...

2023/10/1

Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender Individuals

Transgender Health

Mabel Toribio

Madeline Cetlin

Evelynne S Fulda

Sarah M Chu

Jorge Gomez Tejeda Zanudo

...

2023/2/1

475P Dynamics of TROP2 expression in triple-negative breast cancer

Annals of Oncology

AC Garrido-Castro

J Gomez Tejeda Zanudo

J Navarro

AM Barkell

A Frangieh

...

2023/10/1

The Metastatic Breast Cancer Project: leveraging patient-partnered research to expand the clinical and genomic landscape of metastatic breast cancer and accelerate discoveries

medRxiv

Esha Jain

Jorge Gomez Tejeda Zanudo

Mary McGillicuddy

Daniel L Abravanel

Beena S Thomas

...

2023

Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab

JCO Precision Oncology

Marla Lipsyc-Sharf

Esha Jain

Laura C Collins

Shoshana M Rosenberg

Kathryn J Ruddy

...

2023/6

Structure-based approach to identify driver nodes in ensembles of biologically-inspired Boolean networks

Phys. Rev. Research

Eli Newby

Jorge Gómez Tejeda Zañudo

Réka Albert

2023/3/8

Abstract HER2-10: HER2-10 Dynamics of HER2-low expression in triple-negative breast cancer

Cancer Research

Ana C Garrido-Castro

Lan D Ngo

Edward T Richardson

Allison Frangieh

Ayesha Mohammed-Abreu

...

2023/3/1

Abstract PD6-02: The metastatic breast cancer project-Expanding the clinical, genomic, and transcriptomic landscape of metastatic breast cancer through patient-partnered research

Cancer Research

Esha Jain

Dewey Kim

Jorge Gomez Tejeda Zanudo

Sara Balch

Mary McGillicuddy

...

2022/2/15

Abstract P4-01-06: Genomic and transcriptomic analysis reveals known and novel resistance mechanisms to CDK4/6 inhibitors and sensitivity factors for the response to triplet …

Cancer Research

Jorge Gomez Tejeda Zanudo

Romualdo Barroso-Sousa

Esha Jain

Jorge Buendia-Buendia

Tianyu Li

...

2022/2/15

Abstract OT1-19-01: The metastatic breast cancer project: Generating the clinical and genomic landscape of metastatic breast cancer through patient-partnered research

Cancer Research

Nikhil Wagle

Corrie Painter

Elana Anastasio

Mary McGillicuddy

Esha Jain

...

2022/2/15

Structure-based approach to identifying small sets of driver nodes in biological and biologically-inspired networks

Chaos: An Interdisciplinary Journal of Nonlinear Science

Eli Newby

Jorge Gómez Tejeda Zañudo

Réka Albert

2022/6/1

pystablemotifs: Python library for attractor identification and control in Boolean networks

Bioinformatics

Jordan C Rozum

Dávid Deritei

Kyu Hyong Park

Jorge Gómez Tejeda Zañudo

Réka Albert

2022/3/1

Abstract GS3-09: Loss of ASXL1 tumor suppressor promotes resistance to CDK4/6 inhibitors in ER+ breast cancer

Cancer Research

Dhivya R Sudhan

Sumanta Chatterjee

Jiwoong Kim

Yunguan Wang

Vishal Kandagatla

...

2022/2/15

Parity and time reversal elucidate both decision-making in empirical models and attractor scaling in critical Boolean networks

Science Advances

Jordan C Rozum

Jorge Gómez Tejeda Zañudo

Xiao Gan

Dávid Deritei

Réka Albert

2021/7/16

ER+ breast cancer strongly depends on MCL-1 and BCL-xL anti-apoptotic proteins

Cells

Clara Alcon

Jorge Gómez Tejeda Zañudo

Reka Albert

Nikhil Wagle

Maurizio Scaltriti

...

2021/7/2

Mathematical modeling of the Candida albicans yeast to hyphal transition reveals novel control strategies

PLoS computational biology

David J Wooten

Jorge Gómez Tejeda Zañudo

David Murrugarra

Austin M Perry

Anna Dongari-Bagtzoglou

...

2021/3/29

Relationships among generalized positive feedback loops determine possible community outcomes in plant-pollinator interaction networks

Physical Review E

Fatemeh Sadat Fatemi Nasrollahi

Jorge Gómez Tejeda Zañudo

Colin Campbell

Réka Albert

2021/11/15

See List of Professors in Jorge Gómez Tejeda Zañudo University(Harvard University)

Co-Authors

academic-engine